SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

17 May 2024 09:56

RNS Number : 9130O
Rotork PLC
17 May 2024
 

 

Rotork plc

Share buy-back programme - Tranche 2

 

17 May 2024

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') commenced a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares') of up to £50 million (excluding stamp duty and expenses). Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The first tranche of the Programme concluded in May 2024. The second tranche will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The second tranche of the Programme will run from 17 May 2024 and end no later than 19 July 2024. The aggregate purchase price of all Ordinary Shares acquired under the second tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the Company's 2024 Annual General Meeting (the "2024 Authority"). The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2024 Authority is 86,125,908 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Any Ordinary Shares purchased by the Company will be cancelled.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's 2024 Authority, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting Tel: +44 (0)20 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFIFETEEIDLIS
Date   Source Headline
1st Feb 20234:00 pmRNSTotal Voting Rights
11th Jan 20234:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:30 amRNSTotal Voting Rights
13th Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 20222:00 pmRNSTotal Voting Rights
1st Dec 20227:00 amRNSAppointment of Chair Designate
25th Nov 20223:00 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSTrading Update
17th Nov 20223:30 pmRNSHolding(s) in Company
16th Nov 20223:30 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSDirector/PDMR Shareholding
4th Nov 20225:15 pmRNSHolding(s) in Company
3rd Nov 202211:00 amRNSHolding(s) in Company
2nd Nov 20227:00 amRNSCapital Markets Event
1st Nov 20223:30 pmRNSHolding(s) in Company
1st Nov 202211:00 amRNSTotal Voting Rights
31st Oct 20223:30 pmRNSHolding(s) in Company
28th Oct 20223:00 pmRNSHolding(s) in Company
25th Oct 20229:00 amRNSNear-term emissions targets approved by SBTi
17th Oct 20223:00 pmRNSHolding(s) in Company
13th Oct 20224:30 pmRNSHolding(s) in Company
13th Oct 20223:00 pmRNSHolding(s) in Company
12th Oct 20224:00 pmRNSDirector/PDMR Shareholding
12th Oct 20223:00 pmRNSHolding(s) in Company
11th Oct 20224:00 pmRNSDirector/PDMR Shareholding
5th Oct 20229:30 amRNS2022 AGM Voting Outcome Update Statement
3rd Oct 20225:45 pmRNSHolding(s) in Company
3rd Oct 20223:15 pmRNSTotal Voting Rights
15th Sep 202212:00 pmRNSDirector/PDMR Shareholding
14th Sep 202211:55 amRNSHolding(s) in Company
7th Sep 202211:00 amRNSHolding(s) in Company
1st Sep 202211:00 amRNSTotal Voting Rights
12th Aug 20223:30 pmRNSHolding(s) in Company
11th Aug 20223:30 pmRNSDirector/PDMR Shareholding
10th Aug 20224:45 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNS2022 Half Year Results
1st Aug 202211:00 amRNSTotal Voting Rights
18th Jul 20223:00 pmRNSHolding(s) in Company
15th Jul 20229:22 amRNSHolding(s) in Company
12th Jul 20225:22 pmRNSDirector/PDMR Shareholding
1st Jul 202212:00 pmRNSTotal Voting Rights
20th Jun 202210:30 amRNSPublication of 2021 Sustainability Report
6th Jun 20225:15 pmRNSDirector/PDMR Shareholding
1st Jun 202212:00 pmRNSTotal Voting Rights
30th May 202212:30 pmRNSDirector/PDMR Shareholding
17th May 20224:30 pmRNSHolding(s) in Company
17th May 20223:30 pmRNSDirector/PDMR Shareholding
12th May 202210:30 amRNSDirector/PDMR Shareholding
5th May 20223:30 pmRNSDirector/PDMR Shareholding
4th May 202210:15 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.